Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer
Abstract Pancreatic ductal adenocarcinoma (PDAC) responds poorly to systemic treatment, including new immunotherapeutic approaches. Biomarkers are urgently needed for early disease detection, patient stratification for treatment, and response prediction. The role of soluble CD40 (sCD40) is unknown i...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Portfolio
2023-10-01
|
| סדרה: | npj Precision Oncology |
| גישה מקוונת: | https://doi.org/10.1038/s41698-023-00459-9 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|